Safety, pharmacokinetics and pharmacodynamics of the novel thrombolytic BB-10153 demonstrated in healthy volunteers

被引：0
|
作者：
Curtis, LD
Brown, A
Comer, MB
Senior, JM
Warrington, S
Cornish, A
Ebbs, L
Barrington, P
Dawson, KM
机构：
[1] British Biotech, Oxford, England
[2] Hammersmith Med Res, London, England
来源：
CIRCULATION | 2002年 / 106卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3110
引用
收藏
页码：630 / 630
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of BB-10153, a thrombin-activatable plasminogen, in healthy volunteers
    Curtis, LD
    Brown, A
    Comer, MB
    Senior, JM
    Warrington, S
    Dawson, KM
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (06) : 1180 - 1186
  • [2] Thrombolytic activity of BB-10153, a thrombin-activatable plasminogen
    Comer, MB
    Cackett, KS
    Gladwell, S
    Wood, LM
    Dawson, KM
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) : 146 - 153
  • [3] Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers
    Alain Munafo
    Anthony Priestley
    Ivan Nestorov
    Jennifer Visich
    Mark Rogge
    [J]. European Journal of Clinical Pharmacology, 2007, 63 : 647 - 656
  • [4] Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers
    Munafo, Alain
    Priestley, Anthony
    Nestorov, Ivan
    Visich, Jennifer
    Rogge, Mark
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (07) : 647 - 656
  • [5] Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial
    C. Michael Gibson
    Cafer Zorkun
    Peter Molhoek
    Krzysztof Żmudka
    Mark Greenberg
    Hiltrud Mueller
    Jan Wesdorp
    Hans Louwerenburg
    Alan Niederman
    Jaap Westenburg
    Mahesh Bikkina
    John Batty
    Jobst de Winter
    Sabina A. Murphy
    Carolyn H. McCabe
    [J]. Journal of Thrombosis and Thrombolysis, 2006, 22 : 13 - 21
  • [6] Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial
    Gibson, C. Michael
    Zorkun, Cafer
    Molhoek, Peter
    Zmudka, Krzysztof
    Greenberg, Mark
    Mueller, Hiltrud
    Wesdorp, Jan
    Louwerenburg, Hans
    Niederman, Alan
    Westenburg, Jaap
    Bikkina, Mahesh
    Batty, John
    de Winter, Jobst
    Murphy, Sabina A.
    McCabe, Carolyn H.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 22 (01) : 13 - 21
  • [7] PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS GANAXOLONE IN HEALTHY ADULT VOLUNTEERS
    Barra, Megan
    Vaitkevicius, Henrikas
    Husain, Aatif
    Raja, Shruti
    Macleod, David
    Guptill, Jeff
    Gasior, Maciej
    Rybak, Eva
    [J]. CRITICAL CARE MEDICINE, 2023, 51 (01) : 398 - 398
  • [8] Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers
    Zia-Amirhosseini, Parnian
    Salfi, Margaret
    Leese, Philip
    Yates, Wayne
    Danilenko, Dimitry M.
    Ring, Brian
    Cesano, Alessandra
    Sullivan, John T.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (06) : 558 - 569
  • [9] Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers
    Cabaleiro, Teresa
    Ochoa, Dolores
    Lopez-Rodriguez, Rosario
    Roman, Manuel
    Novalbos, Jesus
    Ayuso, Carmen
    Abad-Santos, Francisco
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (05) : 459 - 469
  • [10] EFFECT OF POLYMORPHISMS ON THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF RISPERIDONE IN HEALTHY VOLUNTEERS
    Cabaleiro, T.
    Ochoa, D.
    Lopez-Rodriguez, R.
    Roman, M.
    Ayuso, C.
    Abad-Santos, F.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 52 - 52
12345